UROGEN PHARMA LTD shareholders Q3 2023

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD 21,823$314,2180.07%
Atom Investors LP 15,660$219,3970.05%
Clal Insurance Enterprises Holdings Ltd 222,159$3,1120.04%
BBR PARTNERS, LLC 26,000$364,2600.04%
Ethos Financial Group, LLC 10,500$147,1050.04%
Laurion Capital Management LP 380,600$5,332,2060.03%
Palo Alto Investors LP 24,500$343,2450.03%
ARK Investment Management 215,272$3,015,9610.02%
MEITAV INVESTMENT HOUSE LTD 91,456$1,294,8880.02%
Jump Financial, LLC 29,600$414,6960.02%
CREDIT SUISSE AG/ 1,060,000$14,850,6000.02%
Schonfeld Strategic Advisors LLC 130,200$1,824,1020.01%
Cubist Systematic Strategies, LLC 130,072$1,822,3040.01%
GSA CAPITAL PARTNERS LLP 10,189$1430.01%
Point72 Asset Management, L.P. 207,733$2,910,3390.01%
State of Wyoming 2,048$28,6920.01%
Tower Research Capital LLC (TRC) 10,390$145,5640.01%
TWO SIGMA INVESTMENTS, LP 120,214$1,684,1980.01%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 15,384$215,5300.01%
Renaissance Technologies 160,300$2,2460.00%
External links

This page lists UROGEN PHARMA LTD's shareholders in Q3 2023. To view UROGEN PHARMA LTD's shareholder history, click here.